Conversely, RB1 altered expression seems to be predictive of nonresponse to intravesical bacille Calmette-Guerin (BCG) +/− IFN-α treatment and tumor recurrence in bladder cancer patients [113, 114]. Here, RB1 is linked to neoplasm.